Publication:
Pregabalin Induced Maculopapular Eruption in an Elderly Male

Simple item page
dc.contributor.authorJaiswal, Sumit
dc.contributor.authorChakrabarti, Sankha Shubhra
dc.contributor.authorRai, Tulika
dc.contributor.authorDhameja, Neeraj
dc.contributor.authorMohan, Atul
dc.contributor.authorYadav, Vandana
dc.contributor.authorKaur, Upinder
dc.date.accessioned2025-01-27T09:44:39Z
dc.date.available2025-01-27T09:44:39Z
dc.date.issued2022
dc.description.abstractBackground: Pregabalin is used in the treatment of neuropathic pain of various etiolo-gies and as an adjuvant in epilepsy. Blockade of the ?2? subunit of L and N-type Ca-channels is its main mechanism of neurotropic action. Compared to other antiepileptics like phenytoin, valproate and lamotrigine, and other neuropathic pain medications such as amitriptyline and duloxetine, pregabalin has a relatively favorable safety profile and hence is a drug of choice for many geriatri-cians. Case Presentation: Here we describe a case of maculopapular rash induced by pregabalin in an older man, which resolved with withdrawal of the offending drug and conservative management. Conclusion: We have also conducted a literature review of similar cases and highlighted the clinical patterns and management strategies for pregabalin-induced skin rashes. � 2022 Bentham Science Publishers.
dc.identifier.doihttps://doi.org/10.2174/1574886317666220309143913
dc.identifier.issn15748863
dc.identifier.urihttps://dl.bhu.ac.in/ir/handle/123456789/12850
dc.publisherBentham Science Publishers
dc.subjectAnticonvulsant
dc.subjectdermatology
dc.subjectidiosyncratic
dc.subjectPregabalin
dc.subjectrash
dc.subjectskin
dc.titlePregabalin Induced Maculopapular Eruption in an Elderly Male
dc.typeArticle
dspace.entity.typePublication
journal.titleCurrent Drug Safety
journalvolume.identifier.volume17

Files

Collections

2022